Prime Medicine Bio (PRME) Bozor kapitallashuvining balans qiymatiga nisbati
Prime Medicine, Inc. (PRME) grafigidagi tasdiqlangan narxlar tarixi noyob patentlar va FDA ning qat'iy nazorati bilan himoyalangan biznesni namoyish etadi. Uzoq muddatli bozor kengayish salohiyati irsiy patologiyalarni tuzatishga bo'lgan ulkan talabga asoslangan bo'lib, ushbu ko'rsatkich 23.99 darajasida turibdi. Joriy moliyaviy holat tashqi moliyalashtirish va ilmiy yutuqlarga tayanadi, chunki tadqiqotlarning ilk bosqichida barqaror daromad mavjud emas.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_PRME_-_Prime-Medicine-Inc._-_Capitalization-to-Book-Value-Ratio "PRME: primemedicine.com Bozor qiymatining balans qiymatiga nisbati 28.04.2023 - 29.10.2026 | 👁️GURU.Markets👁️")
Prime Medicine Inc (PRME) kompaniyasining tahliliy kesimlari
- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi tafsilotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Prime Medicine, Inc.|PRME - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Prime Medicine Corp|PRME - Jamlangan qarz majburiyatlari|Balans kapitallashuviga qarzlar Prime Medicine Corp|PRME - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli qarzi Prime Medicine
Kompaniyaning jamlanma tahliliyoti:Prime Medicine, Inc. - PRME
Ushbu koeffitsient Prime Medicine, Inc. (PRME) kompaniyasining joriy bozor qiymatini uning sof aktivlariga solishtiradi va kapitalning balans qiymatiga nisbatan premium yoki diskontni aks ettiradi. Ilmiy asoslar va DNK huquqlarini himoya qilish strategiyasiga bozor ishonchining yuqoriligi bozor kapitalizatsiyasining balans qiymatiga nisbatida yaqqol ko'ringan bo'lib, bu bozor kompaniyaning intellektual salohiyatini uning moddiy aktivlaridan sezilarli darajada yuqori baholashini tasdiqlaydi.
Prime Medicine, Inc. (PRME) raqobatchilari
TEM: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti qiagen.com (QGEN)|IONS (Ionis) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati RGEN (Repligen Corp)|Bozor qiymatining balans qiymatiga nisbati Avidity (RNA)|CRISPR - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|Bozor kapitallashuvining balans qiymatiga nisbati ultragenyx.com RARE|BEAM - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi SRPT|Twist Bio (TWST) - Bozor qiymatining balans qiymatiga nisbati|10x - Balans qiymatiga nisbatan bozor qiymati|NTLA (Intellia Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|stoketherapeutics.com (STOK) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati BioLife Solutions (BLFS)|Kapitallashuvning sof aktivlarga nisbati Wave Life Sciences Ltd WVE|Bozor kapitallashuvining balans qiymatiga nisbati MAZE (Maze Tx)|Sionna Corp (SION) - Bozor qiymatining balans qiymatiga koeffitsiyenti|TSHA: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati QURE (uniqure.com)|MeiraGTx (MGTX) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati REGENXBIO Inc|SLDB (Solid Bio) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Ocugen Pharma OCGN|Bozor kapitallashuvining balans qiymatiga nisbati PACB|benitec.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati DSGN (Design Therapeutics, Inc.)|Balans qiymatiga nisbatan bozor kapitallashuvi Rocket Pharma (RCKT)|4D Molecular Therapeutics Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Lexeo Therapeutics (LXEO) - Kapitallashuvning sof aktivlarga nisbati|KRRO: Bozor kapitallashuvining balans qiymatiga nisbati|EDIT - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Silence Therapeutics plc|Kapitallashuvning balans qiymatiga nisbati PRQR (ProQR Therapeutics NV)|Bozor kapitallashuvining balans qiymatiga nisbati CDXS|SGMO - Bozor qiymatining balans qiymatiga koeffitsiyenti|Nautilus Bio - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati MGX|Precision BioSciences - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Generation Bio Co. GBIO|Boundless Bio, Inc (BOLD) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati XCUR|IMNN (Imunon Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati RXi Pharmaceuticals (PHIO)|Kapitallashuvning sof aktivlarga nisbati MBIO (Mustang Bio, Inc.)|Balans qiymatiga nisbatan bozor kapitallashuvi transcodetherapeutics.com|Bozor qiymatining balans qiymatiga nisbati Bionano Genomics BNGO|APDN (Applied DNA Corp) - Sof aktivlarga nisbatan bozor kapitallashuvi|BLUE - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati IPA (ImmunoPrecise Antibodies)|Omega Therapeutics, Inc. (OMGA) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Singular Genomics Systems, Inc.|RGLS (Regulus Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Syros Pharmaceuticals, Inc SYRS|Bozor kapitallashuvining balans qiymatiga nisbati TBIO|traconpharma.com - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Unity Biotechnology, Inc. UBX